Clinical Trial Update: Inhaled Sargramostim in Treating Patients With First Pulmonary (Lung) Recurrence of Osteosarcoma [Phase 2]

View source ↗

Summary

A Phase 2 trial tested inhaled sargramostim for patients with first pulmonary recurrence of osteosarcoma. The study has completed and results were posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteosarcoma

Drugs mentioned

• sargramostim (sargramostim)

Snippet

Sponsor: Children's Oncology Group | Conditions: Metastatic Cancer, Sarcoma | Phase 2 | Status: COMPLETED | Results posted: 2015-03-30